It is our goal in this study to compare the outcomes of laparoscopic cholecystectomy with CBD exploration against laparoscopic exploration of CBD using intraoperative endoscopic retrograde cholangiopancreatography (ERCP). Single-stage procedures may reduce the time of hospital stay as a result of advances in technique and more expertise in the area of minimally invasive surgery. We have two groups of people to consider: A total of 120 individuals with gall bladder and CBD stones participated in this trial. All patients had laparoscopic cholecystectomy, and then intraoperative ERCP was used to cure CBD stones in 60 patients; the remaining 60 patients were treated with LCBDE (B). A six-month follow-up was required. In the end, there was no fatality. Group B's operating duration was substantially longer (2.98 hours); the P value for this difference was 0.001. As for conversion, there were no significant changes (P = 0.20). Group A had a considerably lower rate of haemorrhage and collection than group B (P 0.001). Group B had no pancreatic duct damage; the P value was 0.006. P values of 0.07 and 0.2 for penetration and recurrence of stones were found in both groups, however CBD Stricture was significantly higher in group B; P value, 0.005. The conclusion is that both techniques can be employed to treat CBD stones. The less intrusive intraoperative ERCP is, the less time it takes, the less blood it requires, the shorter the hospital stay, and the less likely it is to cause postoperative CBD stricture